ArticleVaccines2026
Efficacy of Multivalent Dengue Vaccine Candidates Predicted In Silico.
Seokhwan Hyeon, Kwangwook Kim, Yoo Jin Na, Mihee Kim, Jaenam Jeong, Byung Chul Kim, Yookyoung Lee
Abstract read
In one paragraphArticle in Vaccines, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
7 authors.
Seokhwan HyeonDivision of Vaccine Development, Center for Vaccine Research National Institute of Infectious Diseases, Korea National Institute of Health, Korea Disease Control and Prevention Agency, Cheongju 28159, Republic of Korea.ORCID 0000-0001-7909-326X Kwangwook KimDivision of Vaccine Development, Center for Vaccine Research National Institute of Infectious Diseases, Korea National Institute of Health, Korea Disease Control and Prevention Agency, Cheongju 28159, Republic of Korea.ORCID 0000-0002-7200-871X Yoo Jin NaDivision of Vaccine Development, Center for Vaccine Research National Institute of Infectious Diseases, Korea National Institute of Health, Korea Disease Control and Prevention Agency, Cheongju 28159, Republic of Korea.ORCID 0009-0003-4566-7714 Mihee KimDivision of Vaccine Development, Center for Vaccine Research National Institute of Infectious Diseases, Korea National Institute of Health, Korea Disease Control and Prevention Agency, Cheongju 28159, Republic of Korea.
Jaenam JeongDivision of Vaccine Development, Center for Vaccine Research National Institute of Infectious Diseases, Korea National Institute of Health, Korea Disease Control and Prevention Agency, Cheongju 28159, Republic of Korea.
Byung Chul KimDivision of Vaccine Development, Center for Vaccine Research National Institute of Infectious Diseases, Korea National Institute of Health, Korea Disease Control and Prevention Agency, Cheongju 28159, Republic of Korea.
Yookyoung LeeDivision of Vaccine Development, Center for Vaccine Research National Institute of Infectious Diseases, Korea National Institute of Health, Korea Disease Control and Prevention Agency, Cheongju 28159, Republic of Korea.
Funding
Korea Disease Control and Prevention Agency 2770000216, 2022-NI-030-02
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
antigen presentationcellular immunitycytokinesdengue vaccinesepitopeshumoral immunityimmunizationneutralizing antibodiesprotein subunit vaccinesviral structural proteins
Identifiers
PMID41746037
PMCPMC12945253
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390